Business Wire

Arm Technology Powers the World’s Fastest Supercomputer

22.6.2020 19:00:00 EEST | Business Wire | Press release

Share

Today at the International Supercomputing Conference (ISC) it was announced that the Fugaku supercomputer, a system jointly developed by RIKEN and Fujitsu Limited, and based on Arm® technology, was awarded the number one spot of the TOP500 list. Having been crowned the world’s most efficient supercomputer on the Green500 list in November 2019, Fugaku was today also given top honors on the HPCG list, a ranking of benchmarks across real-world applications, and the HPL-AI, which rates performance on tasks used in artificial intelligence applications.

“We are incredibly proud to see an Arm-based supercomputer of this scale come to life and thank RIKEN and Fujitsu for their commitment and collaboration,” said Rene Haas, president, IP Group, Arm. “Powering the world’s fastest supercomputer is a milestone our entire ecosystem should be celebrating as this is a significant proof point of the innovation and momentum behind Arm platforms making meaningful impact across the infrastructure and into HPC.”

This achievement represents for the industry a significant evolution in the needs of the modern infrastructure. Compute efficiency is more important than ever, developers are demanding more efficiency and flexibility, and the cloud is driving massive change across the ecosystem. Arm has answered the challenge with its Neoverse™ roadmap and portfolio which aims to deliver the performance, efficiency, and scalability required to enable the next generation of HPC deployments. Arm has also made significant investments across the HPC software ecosystem, enabling seamless migration across instruction sets, cross-platform development, profiling, and debug. Most recently, the company added additional porting capabilities to Arm Compiler for Linux and Arm Allinea Studio to help accelerate applications on current and future Arm CPUs, as more projects of this scale will be based on Arm because of its openness, efficiency, and software ecosystem maturity.

Today’s announcement signals the direction that industry is headed, and through this collaborative effort, a shared purpose of enabling greater choice and flexibility to multiple segments of the infrastructure market has emerged.

The Fugaku supercomputer, which is located at the RIKEN Center for Computational Science, is the flagship system designed to support a number of applications that will address both social and scientific issues as Japan works to achieve “Society 5.0”. Fugaku will accelerate research that spans drug discovery and weather and climate forecasting, to new production processes, and is already being used in the fight against COVID-19 to gain a better understanding of the novel coronavirus.

To learn more about Arm’s journey in HPC, visit the Arm Newsroom.

To read more about the Fugaku supercomputer, read here.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Kristen Ray
armpress@archetype.co

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Xylem Announces Segment Leadership Appointments30.6.2026 14:30:00 EEST | Press release

Xylem Inc. (NYSE: XYL), a leading global water solutions company, today announced two executive leadership appointments, effective July 1, both reporting to President and Chief Executive Officer Matthew Pine. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630087773/en/ Meredith Emmerich has been appointed EVP and President, Measurement and Control Solutions at Xylem. Meredith Emmerich has been appointed EVP and President, Measurement and Control Solutions. Most recently, she served as EVP and President, Applied Water at Xylem. Emmerich joined Xylem in 2024 from Carrier Global Corporation (NYSE: CARR), where she was Vice President of Global Enterprise Solutions and held several senior leadership roles, including leading the Americas Commercial HVAC business and the Global Residential, Light Commercial, and VRF HVAC portfolio. Emmerich succeeds Mike McGann, who will serve as senior advisor to ensure a smooth and orderly tra

Strike Europe Secures Full MiCA Authorization, Unlocking Bitcoin Services Across All 27 EU Member States30.6.2026 14:29:00 EEST | Press release

Strike, a leading Bitcoin financial services company, today announced that its European entity, Zap (Strike) Europe Limited, has been authorized as a crypto-asset service provider by the Malta Financial Services Authority (MFSA) under the EU's Markets in Crypto-Assets Regulation (MiCA) and the Malta Markets in Crypto Assets Act (Cap. 647, laws of Malta) to provide crypto-asset services. The license enables millions of Europeans across all 27 EU member states to access Strike's suite of Bitcoin financial services under a single regulatory framework, replacing the patchwork of national regimes that previously governed the market. Strike has served eligible European customers since April 2024. The MFSA authorization makes that presence permanent and EU-wide, and positions the company among a small group of firms to complete the MiCA process to date. "Europe deserves a Bitcoin-only company focused on doing one thing well, not a multi-asset platform where Bitcoin is an afterthought," said J

OpZira, Inc. Welcomes Scott Thielman, PhD, as Vice President of Product Development30.6.2026 14:17:00 EEST | Press release

OpZira™, Inc., a forward-thinking ophthalmic medical device company founded on a legacy of research excellence, today announced that Scott Thielman, PhD, PE, has joined the company as Vice President of Product Development, effective May 1, 2026. Dr. Thielman brings a unique connection to OpZira’s origins. As Chief Technology Officer of Product Creation Studio, he directed the product development of LumiThera’s Valeda® Light Delivery System - the breakthrough photobiomodulation therapy for dry age-related macular degeneration whose acquisition by Alcon led to the creation of OpZira. His involvement with Valeda gives him firsthand knowledge of the science, clinical vision, and engineering decisions that shaped the technology platform from which OpZira was born. For more than 25 years, Dr. Thielman has directed the development of dozens of FDA-cleared medical devices across ophthalmology, neurostimulation, dermatology, urology, and surgical instrumentation, with partners including Olympus

L&T Technology Services Launches Ainfonix ™ 4.0 to Unlock Engineering Intelligence Across Process Industries30.6.2026 13:45:00 EEST | Press release

L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in Engineering Intelligence Solutions & ER&D Consulting Services, today announced the launch of Ainfonix™ 4.0, a next-generation Engineering Intelligence platform for process industries. Unveiled at EI Live, LTTS’ flagship event that brings together analysts, industry leaders and engineering experts, Ainfonix™ 4.0 marks an important step in the company’s Enterprise AI and Engineering Intelligence strategy. As industrial enterprises accelerate AI adoption, decades of engineering knowledge remain trapped in fragmented drawings, specifications and technical records across disparate systems. Without trusted and accessible engineering data, organizations struggle to realize the full value of AI, automation and digital transformation initiatives. Ainfonix™ 4.0, developed in LTTS’ Sustainability segment, addresses this challenge by transforming engineering artifacts and multi-modal data into structured, asset-linked information

Klick Health Acquires Oxford PharmaGenesis, Bringing Together Unsurpassed Scientific-to-Commercial Capabilities for Life Sciences Clients30.6.2026 13:03:00 EEST | Press release

Focused on taking life sciences companies into the future, Klick Health today announced its acquisition of Oxford PharmaGenesis, the market-leading HealthScience communications consultancy renowned for its scientific and medical expertise, as well as value and market access consulting throughout Europe, Asia-Pacific, and North America. Today’s news brings together two of the leading independent agencies in life sciences. With Oxford PharmaGenesis’ expertise across medical affairs and market access, and Klick's strength in commercial strategy, medical, creative, digital, analytics, and experience design, they can deliver an unparalleled scientific-to-commercial experience. “We are beyond proud to join forces with Chris, Richard, and the entire team at Oxford PharmaGenesis as we focus on helping life sciences clients think holistically about how evidence, medical strategy, access considerations, and stakeholder engagement connect across the lifecycle with a scientific-to-commercial offer

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye